Vandetanib (Caprelsa) - Oncology Nurse Advisor

Vandetanib (Caprelsa)

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews vandetanib (Caprelsa), indicated for symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.


Table of Contents

Slide 4: Dosage and Administration
Slide 11: Cautions, Effects, and Interactions
Slide 20: What to Tell Your Patient
Slide 29: Reference